Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3970691
Max Phase: Preclinical
Molecular Formula: C15H17N3O2
Molecular Weight: 271.32
Molecule Type: Small molecule
Associated Items:
ID: ALA3970691
Max Phase: Preclinical
Molecular Formula: C15H17N3O2
Molecular Weight: 271.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cccc(-c2ncn(/C=C\C(=O)OC(C)C)n2)c1
Standard InChI: InChI=1S/C15H17N3O2/c1-11(2)20-14(19)7-8-18-10-16-15(17-18)13-6-4-5-12(3)9-13/h4-11H,1-3H3/b8-7-
Standard InChI Key: ZPMKPASGUYOHQI-FPLPWBNLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 271.32 | Molecular Weight (Monoisotopic): 271.1321 | AlogP: 2.68 | #Rotatable Bonds: 4 |
Polar Surface Area: 57.01 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.71 | CX LogP: 3.76 | CX LogD: 3.76 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.63 | Np Likeness Score: -0.98 |
1. (2011) Nuclear transport modulators and uses thereof, |
Source(1):